Screening for tuberculosis before TNFalpha antagonist initiation: are current methods good enough?
Bergeron
Anne
A
Herrmann
Jean-Louis
JL
D000907:Antibodies, Bacterial / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007371:Interferon-gamma / Q000378:metabolism; D009169:Mycobacterium tuberculosis / Q000276:immunology; D014374:Tuberculin Test; D014376:Tuberculosis / Q000139:chemically induced / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000907:Antibodies, Bacterial; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma